Oxidized phospholipids on plasminogen influence platelet activation and reactivity

A. Kille (Bad Krozingen)1, K. Kaier (Freiburg im Breisgau)2, T. Nührenberg (Bad Krozingen)3, K. Franke (Bad Krozingen)3, C. M. Valina (Bad Krozingen)3, X. Yang (La Jolla)4, G. Leibundgut (Basel)5, F.-J. Neumann (Bad Krozingen)1, D. Westermann (Freiburg im Breisgau)6, W. Hochholzer (Würzburg)7, S. Tsimikas (La Jolla)4
1Universitäts-Herzzentrum Freiburg / Bad Krozingen Klinik für Kardiologie und Angiologie Bad Krozingen, Deutschland; 2Universitätsklinikum Freiburg Institut für Medizinische Biometrie und Statistik Freiburg im Breisgau, Deutschland; 3Universitäts-Herzzentrum Freiburg / Bad Krozingen Klinik für Kardiologie und Angiologie II Bad Krozingen, Deutschland; 4University of California Vascular Medicine Program, Sulpizio Cardiovascular Center La Jolla, USA; 5Universitätsspital Basel Abt. für Kardiologie Basel, Schweiz; 6Universitäts-Herzzentrum Freiburg - Bad Krozingen Innere Medizin III, Kardiologie und Angiologie Freiburg im Breisgau, Deutschland; 7Klinikum Würzburg Mitte gGmbH Kardiologie & Internistische Intensivmedizin Würzburg, Deutschland
Background: Oxidized phospholipids (OxPL) on plasminogen (OxPL-PLG) are associated with reduced time to fibrinolysis and lower risk of cardiovascular outcomes, but it is not known if they influence platelet function.

Objectives: To evaluate the association of OxPL-PLG with intrinsic and on‑clopidogrel platelet reactivity and long-term cardiovascular events.

Methods: OxPL-PLG was measured in 2040 patients undergoing elective coronary angiography with or without percutaneous coronary angiography (PCI) if indicated in the EXCELSIOR trial. The association of OxPL-PLG to intrinsic and on-clopidogrel platelet reactivity and platelet surface expression of CD62P, CD41 and PAC-1 levels and to myocardial infarction(MI)-free survival and all-cause mortality at a median of 7 years using multivariable Cox regression models was determined.

Results: Elevated levels of OxPL-PLG were inversely and significantly associated with age, male sex, previous MI, PCI, and CABG, and positively will LDL-C, hypertension and obesity, plasminogen levels, platelet count and higher LV function. A significant association were present between OxPL-PLG and intrinsic platelet reactivity in response to ADP (p<0.001) but not collagen (p=0.085). OxPL-PLG was inversely and significantly associated with CD41 (p<0.001), CD62P (p<0.001), PAC-1 (p<0.001) platelet surface expression at baseline and with CD41 (p<0.001), CD62P (p=0.020), after 24 hours but not PAC-1 (p=0.058), p-values for linear relationship. OxPL-PLG and plasminogen were not associated with all-cause of MI-free survival at median 7-year follow-up.